SWA
COLL icon

Sutton Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Sutton Wealth Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-404
Closed -$9.37K – 972
2022
Q4 		$9.37K Hold
404
– – ﹤0.01% 970
2022
Q3 		$6.47K Buy
+404
New +$7.12K ﹤0.01% 1012
2022
Q2 		– Sell
-470
Closed -$9.57K – 1652
2022
Q1 		$9.57K Buy
470
+459
+4,173% +$8.67K ﹤0.01% 940
2021
Q4 		$205 Buy
+11
New +$214 ﹤0.01% 1639
2021
Q3 		– Sell
-371
Closed -$8.77K – 1320
2021
Q2 		$8.77K Buy
+371
New +$8.57K ﹤0.01% 946

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sutton Wealth Advisors's COLL Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2023, closing a stake of 404 shares — an estimated $9.37K sold.

Sutton Wealth Advisors first reported a position in COLL in Q2 2021 and held it in 5 quarters. The position peaked at $9.57K in Q1 2022. 198 funds tracked by Wall St. Rank hold COLL as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 404 Collegium Pharmaceutical shares in Q1 2023, an estimated $9.37K.
  • Sutton Wealth Advisors first reported a position in Collegium Pharmaceutical in Q2 2021 and held it in 5 quarters.
  • Sutton Wealth Advisors's Collegium Pharmaceutical position peaked at $9.57K in Q1 2022.
  • 198 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.